NLRP3 and allergic rhinitis: These outcomes support the findings in rats with allergic rhinitis, further proving that APS inhibits the activation of NLRP3 inflammatory vesicles in rats, hence lowering the production of inflammatory markers (Caspase-1, IL-1β, and ASC).